|
Listeria-Based Therapeutic Cancer Vaccine for Melanoma
|
5R43CA153669-02
|
$70,807
|
Brockstedt, Dirk
|
ADURO BIOTECH
|
|
Bifunctional T cell receptor based immunotherapeutics
|
5R44CA097550-07
|
$979,275
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Tpl2 in Carcinogenesis-Related Inflammation
|
1UA5CA152907-01A1
|
$380,871
|
DeCicco-Skinner, Kathleen
|
AMERICAN UNIVERSITY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
|
1R01CA148748-01A1
|
$335,350
|
Song, Xiao-Tong
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of CD4+ T Cells in Antitumor Immunity
|
5R01CA090327-08
|
$299,889
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
|
5R01CA129350-04
|
$580,820
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
|
5R01CA140602-02
|
$389,282
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VEGFs in tumor lymphatic metastasis
|
4R01CA142262-03
|
$453,456
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-08
|
$1,606,344
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies
|
5R01CA129339-04
|
$342,168
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-04
|
$135,270
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm
|
5R01CA133235-03
|
$342,168
|
ZENG, HUIYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Applying nanosecond pulse electric fields to treat skin cancer
|
5R01CA125722-04
|
$397,073
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
DEVELOPMENT OF A NANOSECOND PULSED ELECTRIC FIELD SYSTEM TO TREAT SKIN CANCER
|
5R44CA123924-03
|
$921,906
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-02S1
|
$140,000
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-02S2
|
$299,726
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
5U10CA139519-02
|
$685,482
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
BMP7 in melanoma niche morphogenesis and homeostasis
|
7R01CA138649-02
|
$328,581
|
HSU, MEI-YU
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-27
|
$2,389,751
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
|
5R01CA138231-04
|
$337,560
|
Frank, Markus
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
5P50CA093683-09
|
$2,185,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular signatures of melanoma histology and progression: A Population Based A
|
4R01CA137365-03
|
$287,153
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multifunctional nanoparticles for targeting aberrant tumorigenic pathways
|
5R01CA135242-02
|
$358,689
|
Sengupta, Shiladitya
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Stem Cell-Engineered Tumor Immunity in Man
|
5P01CA132681-02
|
$2,904,341
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-02
|
$2,446,327
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Validation of Genomic Targets in Melanoma
|
2R01CA114337-07A1
|
$370,543
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Molecular Classification of Primary Cutaneous Melanoma
|
5R01CA122947-05
|
$310,914
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
4th International Symposium on Cancer Metastasis and the Lymphovascular System
|
1R13CA159759-01
|
$3,000
|
LEONG, STANLEY
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Microbial Exposures across the Lifespan and Cancer Risk in Women
|
5R21CA152839-02
|
$178,238
|
CLARKE, CHRISTINA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-28
|
$794,063
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Multifunctional Peptides for (MRI) Imaging
|
1R43CA159771-01
|
$186,994
|
Beattie, Craig
|
CDG THERAPEUTICS, INC.
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-22
|
$240,835
|
Wilbur, Deborah
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-09
|
$364,298
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
|
5R01CA121205-05
|
$321,039
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Endothelial Transdifferentiation of Invasive Tumor Cells
|
5R37CA059702-19
|
$382,123
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-25
|
$1,147,220
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-03
|
$139,569
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S1
|
$91,911
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S2
|
$75,000
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S3
|
$139,999
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-28
|
$2,225,352
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibitors in Src Signaling for Antitumor Therapy
|
5R01CA115674-05
|
$280,320
|
Jove, Richard
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-16
|
$1,008,553
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
GAB2 in metastatic melanoma
|
4R01CA138678-03
|
$324,051
|
CELEBI, JULIDE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma
|
5R00CA133245-04
|
$241,530
|
Zheng, Bin
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|